Cytosurge Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 2

Cytosurge General Information

Description

Developer of synthetic biology enablers designed to implement advanced genetically engineered cell lines. The company applies a patented single-cell bottom-up gene editing process and dynamic gene expression analysis capabilities to construct, evaluate, and debug complex synthetic mammalian cell lines, thereby empowering genetic engineers to concentrate on designing next-generation gene-edited models.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Saegereistrasse 25
  • 8152 Glattbrugg
  • Switzerland
+41 043
Primary Industry
Biotechnology
Corporate Office
  • Saegereistrasse 25
  • 8152 Glattbrugg
  • Switzerland
+41 043

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytosurge Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jul-2026 Completed Generating Revenue
2. Grant 01-Jan-2012 Completed Startup
1. University Spin-Out 01-Jan-2009 Completed Startup
To view Cytosurge’s complete valuation and funding history, request access »

Cytosurge Patents

Cytosurge Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2024506010-A How to generate genetically modified cells Pending 09-Feb-2021
EP-4291668-A1 Method for producing genetically engineered cells Pending 09-Feb-2021
US-20240102053-A1 Method for producing genetically engineered cells Pending 09-Feb-2021
WO-2022171543-A1 Method for producing genetically engineered cells Inactive 09-Feb-2021
EP-4232406-A1 A method of manufacturing a mems device Active 22-Oct-2020 B81C1/00111
To view Cytosurge’s complete patent history, request access »

Cytosurge Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytosurge Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Anker Capital (Zug) Venture Capital Minority
ETH Zurich University
To view Cytosurge’s complete investors history, request access »

Cytosurge FAQs

  • When was Cytosurge founded?

    Cytosurge was founded in 2009.

  • Where is Cytosurge headquartered?

    Cytosurge is headquartered in Glattbrugg, Switzerland.

  • What is the size of Cytosurge?

    Cytosurge has 38 total employees.

  • What industry is Cytosurge in?

    Cytosurge’s primary industry is Biotechnology.

  • Is Cytosurge a private or public company?

    Cytosurge is a Private company.

  • What is Cytosurge’s current revenue?

    The current revenue for Cytosurge is .

  • Who are Cytosurge’s investors?

    Anker Capital (Zug) and ETH Zurich have invested in Cytosurge.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process